We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$11.4B
AUM Growth
+$466M
Cap. Flow
-$346M
Cap. Flow %
-3.04%
Top 10 Hldgs %
11.96%
Holding
2,051
New
157
Increased
773
Reduced
962
Closed
143

Sector Composition

Rank Sector Weight
1 Technology 16.57%
2 Healthcare 11.82%
3 Financials 9.9%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTPBW
2026
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
-114,941
Closed -$18K
KAHC
2027
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
-11,052,298
Closed -$109M
KAHC.WS
2028
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
-439,635
Closed -$53K
SWCH
2029
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-21,521
Closed -$725K
CLR
2030
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-27,362
Closed -$1.83M
AERI
2031
DELISTED
Aerie Pharmaceuticals
AERI
-14,020
Closed -$212K
TEN
2032
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-36,126
Closed -$628K
ECOM
2033
DELISTED
CHANNELADVISOR CORPORATION
ECOM
-18,445
Closed -$418K
IS
2034
DELISTED
ironSource Ltd.
IS
-101,611
Closed -$350K
TWTR
2035
DELISTED
Twitter, Inc.
TWTR
-61,576
Closed -$2.7M
CCXI
2036
DELISTED
ChemoCentryx, Inc.
CCXI
-36,026
Closed -$1.86M
SHLX
2037
DELISTED
Shell Midstream Partners, L.P.
SHLX
-16,990
Closed -$269K
Y
2038
DELISTED
Alleghany Corp
Y
-8,651
Closed -$7.26M
PING
2039
DELISTED
Ping Identity Holding Corp.
PING
-15,302
Closed -$430K
FMTX
2040
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
-14,053
Closed -$280K
CVET
2041
DELISTED
Covetrus, Inc. Common Stock
CVET
-31,845
Closed -$665K
HYT.RT
2042
DELISTED
BlackRock Corporate High Yield Fund, Inc. Rights (expiring October 13, 2022)
HYT.RT
-2,059,751
Closed -$4K
IEA
2043
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-11,953
Closed -$162K
GBT
2044
DELISTED
Global Blood Therapeutics, Inc.
GBT
-28,129
Closed -$1.92M
DRE
2045
DELISTED
Duke Realty Corp.
DRE
-236,369
Closed -$11.4M
CHNG
2046
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-7,491
Closed -$206K
CTXS
2047
DELISTED
Citrix Systems Inc
CTXS
-15,939
Closed -$1.66M
FBC
2048
DELISTED
Flagstar Bancorp, Inc. New
FBC
-24,746
Closed -$826K
BHVN
2049
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-21,291
Closed -$3.22M

Similar funds

Guggenheim Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Guggenheim Capital held 2,051 positions worth $11.4B, up 4.3% from $10.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Guggenheim Capital withdrew a net $346M in Q4 2022, closing 143 positions and reducing 962 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Guggenheim Capital opened a new position in Guggenheim Active Allocation Fund worth $4.25M.

  • Guggenheim Capital's largest Q4 2022 buy was Guggenheim Active Allocation Fund: 315,680 shares worth $4.25M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $43.4M increase.
  • Guggenheim Capital's biggest Q4 2022 reduction was Apple, cutting an estimated $22.7M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $109M.
  • Guggenheim Capital's ten largest holdings make up 12% of its $11.4B portfolio in Q4 2022.
  • Guggenheim Capital opened 157 new positions and closed 143 in Q4 2022.
  • Guggenheim Capital's portfolio value rose 4.3% quarter-over-quarter to $11.4B.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.